DeutschNewstral
Article
metro.us on 2017-07-01 20:43
Big pharma turns to AI to speed drug discovery, GSK signs deal
Related news
- Big pharma turns to AI to speed drug discovery, GSK signs dealmetro.us
Big pharma is banking on AI to speed up drug discoverytimesofmalta.com
Big pharma turns to AI to speed drug discovery, GlaxoSmithKline signs dealThe Globe and Mail
GSK turns around sales of former Novartis meningitis vaccinenewsobserver.com
Swiss pharma Novartis sells stake in joint venture to GSK for $13bnthelocal.ch- FGSK chief questions pharma deal boomft.com
- FGSK chief warns of pharma sector shake-upft.com
- BDrug wars: how AstraZeneca overtook GSK in UK pharmabusinessday.ng
- FGSK consumer chief plans deal spree after split from pharmaft.com
- FGSK chief says lack of pharma ‘baggage’ is an advantageft.com
- FGSK sets out plan to double drug discovery successft.com
- MNvidia announces partnership with GSK focused on drug discoverymarketwatch.com
- BNew AI-Driven Discovery Experienceblog.feedly.com
Will AI Summarization Disrupt Discovery?jdsupra.com
UK medtech company Exscientia raises $60 million to apply AI to drug discoverytech.eu
GSK slips from the No. 1 social media spot in Big Pharmabizjournals.com
GSK facing months of industrial action as workers go on strike at pharma giantThe Daily Record- BExperience 06 – New AI-Driven Discovery Experienceblog.feedly.com
- BDemanding Change at Pharma Giant GSK, Activist Elliott Comes Out of the Shadows4 min readbarrons.com